Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Pharmacokinetics of emedastine difumarate, a new anti-histaminic agent in patients with renal impairment.

Pharmacokinetics of emedastine difumarate, a new anti-histaminic agent in patients with renal impairment. Eur J Clin Pharmacol. 2001 Mar; 56(12):905-10.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.